Soluble CD163 as a Non-Invasive Biomarker in Autoimmune Nephrological and Rheumatological Diseases

Division of Nephrology, Transplantology, and Clinical Immunology at 4th Military Clinical Hospital, Department of Non-Procedural Clinical Sciences, Faculty of Medicine, Wroclaw University of Science and Technology, Wrocław, Poland

Clinical Research Support Center, 4th Military Hospital, Wrocław, Poland

Paweł Poznański

Wojciech Tański

Division of Internal Medicine at 4th Military Clinical Hospital, Department of Non-Procedural Clinical Sciences, Faculty of Medicine, Wroclaw University of Science and Technology, Wrocław, Poland

Anna Skotny

Clinical Research Support Center, 4th Military Hospital, Wrocław, Poland

Harvard T.H. Chan School of Public Health—Executive and Continuing Education, Harvard University, Boston, USA

Metrics

Articles in this issue

DOI: https://doi.org/10.2478/aite-2026-0024 | Journal eISSN: 1661-4917

Journal RSS Feed

Language: English

Submitted on: Feb 28, 2026

Accepted on: Jun 18, 2026

Published on: Sep 1, 2026

Published by: Hirszfeld Institute of Immunology and Experimental Therapy

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

sCD163,

Macrophages,

Lupus nephritis,

IgA nephropathy,

ANCA-associated vasculitis rheumatoid arthritis,

Spondyloarthritis

Related subjects:

Medicine,

Basic medical science,

Biochemistry,

Immunology,

Clinical medicine,

Clinical medicine, other,

Clinical chemistry

© 2026 Dorota Kamińska, Paweł Poznański, Wojciech Tański, Anna Skotny, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 74 (2026): Issue 1 (January 2026)